Trial Profile
Study of MOR107 in inflammatory and fibrotic disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs MOR 107 (Primary)
- Indications Fibrosis; Inflammation
- Focus Adverse reactions
- 14 Sep 2015 New trial record
- 08 Sep 2015 According to MorphoSys media release, company is planning to start this trial by 2016.